Published Study Reveals Next Pharmaceuticals’ Flavoxine? Reduces Multiple Heart Health Risk Factors Including High Cholesterol
Next Pharmaceuticals announced the results of their placebo-controlled, randomized, double-blind clinical trial, which revealed multiple heart health benefits of Flavoxine. The published study concluded that Flavoxine significantly reduced LDL-cholesterol and triglycerides, while it significantly decreased blood pressure and fasting blood glucose.
More: continued here
Filed under: Cholesterol on June 30th, 2008